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Abstract
Background: Due to considerable health status differences in the elderly population, research limited to narrow
age-spans might be an advantage. In this population-based controlled study we compare short-term (<5 years)
(STS) and long-term (≥5 years) (LTS) cancer survivors and cancer-free controls aged 60-69 years from two
Norwegian health registers; the Health Survey of North-Trøndelag County (HUNT-2 study) and the Cancer Registry
of Norway (CRN). We examined possible factors associated with being cancer survivor.
Methods: Among 9,089 individuals aged 60-69 who participated in HUNT-2, 334 had been diagnosed with
invasive primary cancer from 1 month to 42 years before HUNT-2 according to CRN and self-report. An overall
random sample of controls without cancer five times larger than the sample of cases (N = 1,670) were drawn from
the parent cohort.
Results: The cancer sample comprised 128 STS and 206 LTS. For most variables no significant differences were
observed between LTS and STS. LTS were significantly more women, and cases with gynaecological cancer, with
physical impairment and more thyroid diseases compared to STS. When comparing all the survivors with controls,
the survivors showed significantly higher rate of pensioning, decreased self-rated health, more physical impairment
and thyroid diseases, daily use of medication and psychotropics and higher level of anxiety and Framingham Risk
score. Multivariate logistic regression analysis showed that increasing age, being female, physical impairment and
thyroid diseases all were significantly associated with being survivor versus controls.
Conclusion: STS and LTS showed mostly similar situation. Compared to controls, the survivors reported somewhat
poorer physical and mental health, but these differences were of doubtful clinical significance.
Background
In Norway 74% of those who are diagnosed with cancer,
are 60 years or older [1], and the life expectancy is 78.2
years in men and 82.7 years in women [2]. Elderly
Norwegians who get cancer, therefore often have a con-
siderable lifetime ahead, and studies of their health and
psychosocial situation are of substantial interest for pre-
vention of morbidity and possible side effects of treat-
ment. Cancer survivorship can be seen as an experience
with different phases [3]. The concept may comprehend
a stage of living with cancer with or without “treatment”
or management [4], or concern patients with cancer
“that is controlled with ongoing or periodic treatment”
[5]. In most cases five years beyond diagnosis [6] or
from end of primary treatment [7] are suggested as the
border between short- and long-term survivorship.
Rowland & Bellizzi (2008) [8] highlight the cancer sur-
vivors’ situation as a melting pot with ingredients of
more or less successful coping with bodily, social, men-
tal, existential and economic aspects in life. Conse-
quences of cancer diagnoses and treatment may persist
over time with fatigue, digestive problems, sexual
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diovascular disease and osteoporosis, as well as changed
attitudes to life as a whole. Several population-based
studies of cancer patients have described their psychoso-
cial situation and morbidity, but most of them cover
large age intervals. Hewitt et al. reported findings from
the American National Health Interview Study [9] com-
paring cancer patients aged 18 to 75 years to individuals
without cancer. Their main findings, and thereby the
core challenges in cancer survivors, are poorer health,
more functional limitations, higher prevalence of comor-
bid medical diagnoses, and limitations in performing
activities of daily life. However, an age span between
18 and 75 years makes it difficult to specify findings
relevant to young, middle-aged or elderly survivors, as
their situation and expectations vary considerably with
the different phases of life [10]. Blank & Bellizzi [11]
studied prostate cancer survivors aged 47 to 88 years
and found that increasing age was moderately associated
with comorbidity. An optimally designed study includes
stratification of some variables in order to create a
homogenous sample. In our study we selected cancer
survivors in the age span 60-69 for specifications related
this age category, which in Norway represent the end of
active work life for the majority of people. Alfano et al.
(2007) [12] report on a sample of cancer survivors aged
29 to over 70 years without age stratification of the ana-
lyses. This sample will certainly allow for reflections
about the influence of age related concerns when study-
ing morbidity, psychosocial aspects and lifestyle.
Deimling et al. [13] studied older adult survivors
(mean age 72.3 years, range <60 - >75 years) reporting
that elderly cancer survivors were vulnerable for func-
tional difficulties, and to comorbid health conditions,
where pain was the most common symptom attributed
to cancer or cancer treatment. Sweeney et al. [14]
focused on elderly female cancer survivors, 57% of them
older than 68 years (mean age 72 years, range 66-82
years), who carry a risk of confounding of age-related
morbidity with the effects of cancer and its treatment.
Several functional limitations were significantly more
frequently reported among elderly female cancer survi-
vors compared to controls without cancer. In a study
among elderly cancer survivors, ≥65 years, Grov et al.
[15] showed significant associations between somatic
comorbidity, lifestyle, and somatic symptoms.
In order to prevent morbidity and long-term effects
after cancer and its treatment, health care personnel
should be aware of cancer survivors’ vulnerability for
health problems, unfavorable life style, and psychosocial
challenges. These are factors that we hypothesize to be
associated with the survivors’ age and time since
diagnosis.
We hold the view that morbidity studies of cancer
survivors should be restricted to defined age spans.
Therefore, this study focused on cancer survivors aged
between 60 and 69 years. This decade includes regular
retirement (from 62 to 69 years of age in Norway), and
increasing risk of somatic morbidity and symptomatol-
ogy. In the decade from 60 to 69 years, the rate of cog-
nitive impairment is low, and self-report is therefore a
reliable mode of data collection. Lifestyle changes are
still possible with the aim to decrease the risk for cardi-
ovascular comorbidity and long-term health effects after
cancer treatment [16,17].
An ideal study would have a longitudinal design with
follow-up for the selected groups of cancer survivors
(60-69 years) to be continued for ten years (to the survi-
vors reach the age of 70-79). The study should have no
dropouts, and the treatment given to all cancer patients
should be well documented, and all relevant variables
for the study of morbidity, lifestyle and psychosocial
situation must be covered. Norway has special opportu-
nities in research on cancer survivors due to the unique
person number allowing for linkage between high qual-
ity health-related registries. In this study, persons aged
60 to 69 years participating in the Health Survey of
Nord-Trøndelag County 1995-97 (HUNT-2) were linked
to the Cancer Registry of Norway (CRN).
Since the dataset from the HUNT-study covers many
relevant variables about morbidity, psychosocial situation
and lifestyle, we considered that our study could give
valid information regarding several aspects concerning
the situation of cancer survivors. All these variables are
relevant for planning health care service for cancer survi-
vors. Compared to other studies in the field, our study
had the following advantages: internationally accepted
schedules like the HADS, the Rosenberg instrument, and
the Framingham Risk Index, in addition to a variety of
somatic symptoms included by the gold standard of self-
report, and a valuable link to cancer specific register data
b yt h eC a n c e rR e g i s t r yo fN o r w a y( C R N )w h i c hc o n t r i -
butes with data on quite reliable cancer diagnoses.
The aim of the study was to examine morbidity, life-
style and psychosocial situation in a sample of patients
with invasive cancer compared to a random sample of
controls without cancer. 1) We first compared cancer
patients with primary diagnosis <5 years before HUNT-2
(Short Term Survivors, STS) to those who had their diag-
nosis ≥5 years before HUNT-2 (Long Term Survivors,
LTS). 2) We then compared the cancer survivors (SURV)
with controls without cancer (controls). Our hypotheses
were for 1) that no significant differences between short-
and long-term survivorship would be demonstrated, and
for 2) that SURV would show more morbidity, and simi-
lar lifestyle and psychological situation as controls.
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Sampling
The second Health Survey of Nord-Trøndelag County
(HUNT-2) invited all inhabitants of the County aged
20 years and above to a health survey. The survey was
done locally through the 24 municipalities of the County
between August 1, 1995 and June 30, 1997. The perso-
nal invitation provided time and place for a simple phy-
sical examination, non-fasting blood sampling, and also
included a questionnaire (Form 1), to be filled in and
delivered at the examination. At the examination a sec-
ond questionnaire (Form 2) was handed out to be
returned by prepaid mail. Details of the HUNT-2 study
are given elsewhere [18], (http://www.hunt.ntnu.no).
Within the 60-69 years age group 10,611 individuals
were invited to HUNT-2, and 9,089 (86%) participated.
Report of all cancer cases occurring in Norway to the
C R Nh a sb e e nm a n d a t o r yb yl a ws i n c e1 9 5 3 ,a n dt h e
CRN is considered as a quite complete and reliable reg-
istry concerning cancer localization and invasiveness.
B a s e do nt h ep e r s o nn u m b e r sa na u t h o r i z e dl i n k a g e
between HUNT-2 and the CRN, identified 428 partici-
pants (5%) with at least one diagnosis of invasive cancer
diagnosed >1 month before their HUNT-2 examination.
Basal cell and squamous cell carcinomas (skin cancer)
were excluded due to its superficial character not incor-
porated in our way of defining ‘invasive cancer’,w h i c h
means more aggressive invasion into the tissue. From
the 428 we excluded 71 participants found in the CRN
b u tw h od i dn o ts e l f - r e p o r tc a n c e r ,a n d2 3p a r t i c i p a n t s
who had not filled in Form 2. This left us with a sample
of 334 cancer patients (cases), among them 128 (38%)
had been diagnosed with cancer <5 years before HUNT-
2( S T Sg r o u p )a n d2 0 6( 6 2 % )≥5 years before HUNT-2
(LTS group).
Among the 8,661 participants in the parent cohort not
registered in the CRN, we excluded 56 who reported
cancer but did not have a record in the Registry, and
609 participants who did not fill in Form 2. From the
rest of 7,996 participants in the parent sample, we drew
an overall random sample of five controls for each case,
and these 1,670 participants represented the control
group (NORM).
Variables
Demographic variables
Civil status was dichotomized into those married and
those single, separated, divorced or widowed. Level of
basic education was dichotomized into < 10 years and
≥10 years. The work situation was divided into those
being in paid work or independent business versus
those on age or disability pension. Economic problems
last year were defined as reported problems paying bills
during that time. Social network was assessed by having
enough friends or not, and social activities were defined
as being active in social clubs ≥1 time/month or not.
Lifestyle variables
Daily smoker was registered for persons who reported
daily consumption of cigarettes. Body Mass Index (BMI)
was calculated. The level of physical activity was divided
into “minimal” and “moderate or more” according to
Thorsen et al. [19]. The “minimally active” category
represents not sweaty/breathless activity ≥1h o u rp e r
week, and either no or <1 hour per week of higher-level
activity (sweaty/breathless). The “moderate or more”
category is defined by higher-level activity ≥1h o u rp e r
week. The Framingham Risk Index score was calculated
for males and females according to algorithms of the
Adult Treatment Panel [20], which includes weighted
assessments of cholesterol, high density cholesterol,
smoking and blood pressure, and indicates to what
degree a person is at risk for developing coronary heart
disease or sudden cardiac death within 10 years.
Somatic morbidity variables
Impairment was defined as caused by chronic disease,
injury or somatic or mental morbidity leading to
reduced activity of daily living, and divided into mainly
physical or mental impairment. Self-rated health was
rated to be “good” (very good/good) or “poor” (poor/
very poor). Somatic diseases were asked for by the ques-
tion: “Has a doctor ever said that you had...?": myocar-
dial infarction, angina pectoris, stroke, diabetes, thyroid
disease (either hyperthyroidism, hypothyroidism, goiter
or other thyroid diseases), osteoporosis, arthritis/
arthroses (rheumatoid arthritis, arthrosis or ankylosing
spondylitis), and musculo-skeletal diseases (including
fibromyalgia). A diagnosis of either myocardial infarc-
tion, angina pectoris, or stroke, qualified for a diagnosis
of cardiovascular disease. Comorbid disease(s) were pre-
sent if the patients had ≥1o ft h e s ed i s e a s e s .Somatic
symptoms covered gastrointestinal ones (nausea, heart-
burn, diarrhea, or constipation) if they had caused
“much bother last year”,a n dheadache defined as
attacks during the last year. Muscular pain and stiffness
affecting activities of daily living last month was rated as
present or absent.
Regular use of medication last year concerned daily
use of any medication, and regular use of antihyperten-
sives, analgesics, and psychotropics (hypnotics, anxioly-
tics, and/or antidepressants) were registered. Daily use
refers to daily consumption during the last 12 months.
Mental distress variables
Anxiety and depression were self-rated with The Hospital
Anxiety and Depression Scale (HADS). The psychometric
properties of the scale had been tested in HUNT-2
[21,22]. Scores on the anxiety and depression sub-scales
ranged from 0 to 21, respectively, and higher scores mean
increased symptom load. HADS-defined caseness of
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the subscale scores [21]. The correlation between the anxi-
ety and depression subscales were Spearman’sr=0 . 6 2 .
Internal consistency by Cronbach’s coefficient a was 0.85
for the anxiety-subscale, and 0.78 for depression.
Rosenberg self-esteem score was assessed with four of
the 10 items introduced by Rosenberg [23]. These items
were self-rated on four-point Likert scales ranging from
“strongly agree” to “strongly disagree” [24], and the
score ranged from zero to 12, with higher scores mean-
ing better self-esteem. Internal consistency measured by
Cronbach’s coefficient a was 0.69.
Sleeping problems were present if they regularly
occurred for one or more nights a week. Alcohol pro-
blems were present in respondents who scored positively
on one or more of the four CAGE items [25,26].
Data from the Cancer Registry (CRN)
For all cancer patients the following data were collected
from the CNR: 1) date of first cancer and the interval to
their HUNT-2 participation; 2) localization of cancer
were categorized into six groups according to organ sys-
tems, where skin cancers were excluded.
Statistical analysis
Data were analyzed by SPSS-PC, version 15.0. Continu-
ous variables were examined with t-tests, and categorical
variables with c
2-tests. Non-parametric tests were
applied in case of skewed distributions. Statistically sig-
nificant group differences were examined for clinical sig-
nificance by means of effect sizes (ESs) [27]. Clinical
significance is the conclusion that a group difference has
an effect of practical meaning to patients and health
care providers. Even though a group difference is found
to be statistically significant, this difference may not be
clinically significant. For continuous variables we used
Cohen’s coefficient d, and for 2 × 2 contingency tables
the differences between arcsine transformed proportions
and ES values ≥0.40 were considered as clinically signifi-
cant based on the recommendations of Cohen [28-30].
Internal consistencies of scales and subscales were
examined by Cronbach’sc o e f f i c i e n ta.As t a n d a r d
(unconditional) multivariate logistic regression analysis
examined the associations between the dependent vari-
able (cancer survivors or controls), and the selected
independent variables showing significant associations in
the bivariate analysis. Strength of association was
expressed as odds ratio (OR) with 95% confidence inter-
val (95% CI). The significance level was set at p < 0.05,
and all tests were two-tailed.
Ethics
The HUNT-2 study was approved by The Norwegian
Data Inspectorate and by The Regional Committee for
Medical Research Ethics, Health Mid-Norway. All parti-
cipants in HUNT-2 gave written informed consent.
Results
Characteristics of the cancer survivors
No significant age difference was found between STS
and LTS. The mean time from diagnosis of cancer to
the HUNT-2 examination was 2.3 years (median 2.1)
among STS and mean 13.8 (median 12.6) among LTS,
which was to be expected considering the definitions of
the STS and LTS. The time interval between diagnosis
and HUNT-2 was significant longer in female cancer
survivors, and they had lived a mean of 12 years (med-
ian 8.5) since their primary diagnosis. For male survivors
the comparable mean was 7.5 years (median 5.0). Ana-
lyses on 5-year survival show that of the 334 partici-
pants in this study 78 have died of cancer, where 38 of
them have survived less than 5 years (data until 2005).
The most common localizations of cancer were breast,
gastrointestinal tract, and the group of other organ sys-
tems. STS contained significantly less gynaecological
cancer (ES = 0.41) and more prostate cancer (ES = 0.62)
than LTS, and both these findings showed clinical
significance.
Comparisons of STS and LTS
There were significantly more females among LTS than
STS (ES = 0.33), and therefore all analyses comprising
morbidity and lifestyle variables are adjusted for sex.
Concerning other socio-demographic, work, and social
activity variables no significant differences were
observed between LTS and STS (Table 1).
As to somatic variables LTS showed significantly more
thyroid diseases (ES = 0.36) and more physical impair-
ment (ES = 0.24) than STS, but no other somatic vari-
ables showed significant group differences (Table 2).
Neither was any significant differences observed con-
cerning daily use of any medication or regular use of
analgesics, psychotropics or antihypertensive medication.
No significant differences concerning mental morbid-
ity or lifestyle variables were observed between LTS and
STS (Table 2).
Comparisons between cancer survivors and controls
Since only two variables among socio-demographic,
somatic, mental and lifestyle ones showed significant
differences (thyroid diseases and physical impairment),
we found it allowable to analyze LTS and STS taken
together as survivors versus controls.
The survivors was significantly older than the controls
(ES = 0.24), and there were significantly more females
among survivors (ES = 0.26). In the analyses of other
variables we adjusted for age and sex. Only two signifi-
cant differences among socio-demographic were
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on pensions (ES = 0.25) and a lower proportion with eco-
nomic problems (ES = 0.17) than the controls (Table 3).
Significantly more survivors than controls reported
poor self-rated health (ES = 0.26), physical impairment
(ES = 0.26) and thyroid diseases (ES = 0.23) compared
to controls (Table 4), but none of these differences
showed clinical significance (Table 4).
The proportions of individuals that used daily medica-
tion (ES = 0.16), analgesics, or psychotropics (ES = 0.17)
were all significantly higher among survivors compared
to controls. However these differences did not reach
clinical significance.
Survivors showed significantly higher level of anxiety
(ES = 0.20) and more HADS-defined cases of anxiety
(ES = 0.31) than controls. The other mental variables
did not show any significant differences between the
groups (Table 4).
No significant differences between the groups were
observed for any of the lifestyle variables, except for The
Framingham Risk Index mean score which was signifi-
cantly higher in survivors compared to controls (ES =
0.14). However, the proportions with a risk >20% did
not differ significantly between the groups.
The standard multivariate logistic regression analysis
with ‘survivors versus controls’ as dependent variable
showed that increasing age, female sex, lack of economic
problems, physical impairment, and presence of thyroid
diseases were significantly associated with the dependent
variable (Table 5).
Discussion
This study of cancer survivors aged 60-69 years and a ran-
dom sample of controls had two main findings: 1) Among
LTS there were significantly more females, and more cases
with gynecological cancer, physical impairment, thyroid
diseases, but fewer cases with prostate cancer than among
STS. Only the differences concerning cancer types reached
clinical significance, however they represent 94/334
patients (28%), which leaves limited reason to believe, that
Table 1 Demographic and clinical characteristics of short- and long-term cancer survivors
Variables Short-term
survivors
(N = 128)
Long-term
survivors
(N = 206)
p-value Effect
Size
Age, mean (SD) 65.3 (2.9) 65.0 (3.0) 0.28
Time since diagnosis (years)
Mean (SD) 2.3 (1.4) 13.8 (7.2) <0.001 2.00
Median 2.1 12.6
Range 0.1 - 5.0 5.1 - 42.2
Localization of cancer, N (%)
Respiratory tract 5 (4) 11 (5) 0.79
Gastrointestinal tract 28 (22) 32 (15) 0.14
Breast 33 (26) 57 (27) 0.80
Gynecological 13 (10) 52 (25) 0.001 0.41
Prostate 24 (19) 5 (2) <0.001 0.62
Other organ systems 25 (20) 49 (23) 0.41
Sex, N (%) 0.002 0.33
Male 57 (44) 58 (28)
Female 71 (56) 148 (72)
Civil status, N (%) 0.95*
Married 95 (74) 147 (71)
Single, separated, divorced, widowed 33 (26) 59 (29)
Level of basic education, N (%) 0.66*
<10 years 76 (63) 130 (68)
≥10 years 45 (37) 61 (32)
Work status, N (%)
Paid work, independent business 37 (29) 51 (25) 0.71*
Disability or age pension 89 (70) 144 (70) 0.95*
Economic problems last year, N (%) 14 (11) 22 (11) 1.00*
Have enough friends, N (%) 106 (82) 161 (78) 0.06*
Active in social clubs ≥1 time/month, N (%) 47 (40) 94 (51) 0.11*
*Adjusted for sex.
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between the groups of survivors. 2) A considerable num-
ber of significant differences were observed between can-
cer survivors and controls. The survivors were
significantly older and had a higher proportion of females
than controls. Among survivors a significant higher pro-
portion were pensioned, had poorer self-rated health, phy-
sical impairment, thyroid diseases, daily use of medication
and psychotropics, and HADS-defined anxiety disorders
than controls. The mean scores on anxiety and Framing-
ham Risk Index were also significantly higher among sur-
vivors than controls. None of these differences showed
clinical significance, however. We conclude that survivors
in the age group of 60-69 years are worse of in several
respects compared to controls. However, the clinical con-
sequences of these differences are in need of further inves-
tigation. In multivariate analysis having thyroid diseases
was significantly and positively associated with being survi-
vor, and such diseases were significantly more common
among LTS than STS, so investigations of the thyroid and
follow-up of such diseases seems worthwhile in the group
of survivors.
Somewhat poorer self-rated health and more physical
impairment in survivors than among controls are in line
with the findings from the study by Hewitt et al. [9],
where especially the subgroup ≥65 years with a history
of cancer reported significantly poorer health and more
disability than age-matched controls without cancer.
Our results support the study by Yabroff et al. [31] in
which cancer survivors reported significantly poorer
health compared to matched controls. Yabroff et al. also
concluded with higher rate of pensioning and less work
ability in survivors compared to controls. However, the
comparison with that study might be biased due to
their large age span (<20 - ≥70 years). The problem
regarding comparisons with studies using long age
spans is also relevant in relation to other studies such
as Hewitt et al. [9], Deimling et al. [13], and Blank &
Bellizzi [11].
Except for thyroid diseases, survivors did not have
more somatic diseases or bothering somatic symptoms
than controls. The thyroid findings might be related to
the high proportion of breast cancer patients in the
study since a clear association with thyroid diseases has
been shown in such patients [32]. In multivariate analy-
sis having thyroid diseases was significantly and posi-
tively associated with being survivor, and such diseases
were significantly more common among LTS than STS,
so investigations of the thyroid and follow-up of such
diseases seem worthwhile in the group of survivors. Phy-
sical impairment was also significantly associated with
survivor status in the multivariate analysis, but since we
have no further details on this variable, evaluation and
interventions cannot be suggested by us.
Table 2 Somatic and mental morbidity of short- and
long-term cancer survivors
Variables Short-
term
survivors
(N =
128)
Long-
term
survivors
(N =
206)
p-
value*
Effect
Size
Self-rated health 0.62
Good health 59 (47) 92 (45)
Poor health 66 (53) 112 (55)
Functional impairment
Physical impairment 16 (13) 45 (22) 0.04 0.24
Mental impairment 8 (6) 15 (7) 0.89
Somatic diseases
Infarction, angina or stroke 18 (14) 26 (13) 0.96
Diabetes 5 (4) 9 (4) 0.82
Thyroid diseases 9 (7) 39 (19) 0.01 0.36
Osteoporosis 3 (2) 14 (7) 0.16
Arthritis, arthrosis 31 (24) 49 (24) 0.62
Musculo-skeletal diseases 18 (14) 36 (18) 0.45
≥1 comorbid disease(s) 57 (45) 112 (54) 0.12
Significant somatic symptoms
Muscular pain and stiffness
affect-
ting daily activities last
month
18 (14) 48 (23) 0.05
Gastrointestinal symptoms
last year
11 (9) 16 (8) 0.82
Headache last year 24 (19) 52 (25) 0.35
Regular use of medication last
year
Daily use of any
medication
76 (59) 114 (53) 0.55
Analgesics 21 (16) 31 (15) 0.83
Psychotropics 25 (19) 43 (21) 0.99
Antihypertensives 25 (20) 50 (24) 0.33
Mental variables
HADS-Anxiety, mean (SD)
a 4.8 (4.1) 4.8 (3.7) 0.78
HADS-Depression,
mean (SD)
a
4.1 (3.3) 4.4 (3.2) 0.56
Self-esteem score,
mean (SD)
7.9 (2.1) 7.7 (2.2) 0.54
Sleeping problems, N (%) 30 (25) 59 (32) 0.33
Alcohol problems, N (%) 8 (6) 17 (8) 0.15
Lifestyle variables
BMI, mean (SD) 27.6 (3.8) 27.6 (4.8) 0.70
Physical activity, N (%)
Minimal 40 (31) 80 (39) 0.63
Moderate or more 88 (69) 126 (61) 0.48
Daily smoker 26 (20) 55 (27) 0.38
Framingham risk score
Framingham sum score,
mean (SD)
16.1 (2.8) 16.6 (3.0) 0.15
Framingham risk >20%,
N (%)
69 (54) 123 (60) 0.48
*Adjusted for sex
a Non-parametric test.
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vors and controls for cardiovascular diseases or antihy-
pertensive medication. We had expected such difference,
or at least significant differences between the groups for
Framingham Risk Index. The latter was found for the
mean scores, but the ES = 0.14 indicated doubtful clini-
cal relevance, particularly since no significant difference
was found for the high risk (>20%) cases. Previous stu-
dies have reported increased heart-related comorbidity
in cancer survivors, but differences in sampling can
explain the divergent findings [13,16,17,33].
We observed no significant differences between survi-
vors and controls on variables that are relevant for life-
style interventions. The group in need of such
interventions must therefore be defined by other vari-
ables than survivor status.
As observed in the study of Mehnert & Koch [34], our
findings also support the lower level of self-rated health in
cancer survivors compared to controls. However, Mehnert
& Koch found a significantly higher level of depression in
elderly breast cancer survivors compared to controls,
while that was not the case in our study (mean 4.4, SD 3.5,
a n dm e a n4 . 1 ,S D3 . 3 ,p=0 . 2 6f o rf e m a l es u r v i v o r sa n d
controls, respectively). In contrast, we observed a higher
level of anxiety in survivors compared to controls, however
not to clinically significant degree. Since the HADS anxiety
and depression subscales are highly correlated, the two
studies have in common a higher level of mental distress
in survivors compared to controls.
To our knowledge there are hardly any studies that
compare LTS and STS on the variables examined in this
study. Our hypothesis of significant differences between
the groups was hardly confirmed. However, the hypoth-
esis of more morbidity among survivors compared to
controls was confirmed. Health care personnel should
be aware of health problems in cancer survivors by
highlighting assessments of their physical and mental
health. Poor physical health and mental distress might
have implications for the way cancer survivors cope
with e.g. performance of activity of daily living, their use
of medication, and their social capability.
The few significant differences observed could be
due to chance since we did a considerable number of
comparisons. If we apply Bonferroni’s correction for
multiple comparisons we get a p-value of 0.002 (0.05/
32), and no significant differences emerge. Few signifi-
cant differences between LTS and STS could reflect
that survivorship is a relatively stable state, but not
necessarily without problems. As with other chronic
diseases cancer survivors have to cope with challenges
coming up now and then, and our findings indicate
that cancer survivors find ways to deal with conse-
quences of cancer treatment and side effects during
the survivorship trajectory. We find the lack of differ-
ence between STS and LTS in a mixed sample of can-
cer survivors of considerable interest, and this result
should be focus for more studies.
The strength of this study is the data collection com-
bining data from a large health survey with a high qual-
ity cancer registry. Due to this combination, we also
had opportunity to draw at random a control group
from the same parent population, which is an advantage
Table 3 Demographic, work, social activity and health care consumption s of cancer survivors and controls
Variables Survivors
(N = 334)
Controls
(N = 1,670)
p-value Effect
size
Age at survey, mean (SD) 65.1 (2.9) 64.4 (2.9) <0.001 0.24
N (%) N (%)
Sex <0.001 0.26
Males 115 (34) 792 (47)
Females 219 (66) 878 (53)
Civil status <0.43*
Married 242 (73) 1,280 (77)
Single, separated, divorced, widow(er) 92 (27) 387 (23)
Level of basic education 0.77*
<10 years 206 (66) 953 (62)
≥10 years 106 (34) 583 (38)
Work situation
Paid work, independent business 88 (26) 593 (36) 0.30*
Disability or age pension 233 (70) 961 (58) 0.006* 0.25
Economic problems last year 36 (12) 288 (18) 0.02* 0.17
Have enough friends 267 (87) 1,396 (87) 0.75*
Active in social clubs ≥1 time/month 141 (46) 761 (48) 0.33*
* Adjusted for age and sex.
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p r o v i d et h eo p p o r t u n i t yt os t u d yas h o r ta g es p a no f
cancer survivors with a sufficient sample size. The use
of internationally accepted schedules like the HADS, the
Rosenberg instrument, and the Framingham Risk Index
is an additional strength.
On the other hand, some limitations have to be con-
sidered when interpreting the results from this study.
O n ei st h el a r g et i m eo fs u r v i v o r s h i ps t u d i e dr a n g i n g
from 0.1 - 42.2 years. Fourteen per cent of those aged
60-69 years did not participate in HUNT-2. Among the
1,522 non-responders in the age group 60-69, 225 (14%)
had invasive cancer, while in the participant group
(9,089) 334 (4%) had invasive cancer. These findings
represent a source of systematic bias, and we suggest
that one explanation is that they did not want to partici-
pate in the survey due to health problems. Therefore we
cannot exclude a selection bias concerning the cancer
survivors included compared to the survivors in the
population. Additionally, more somatic symptoms might
be present for the respondents, but they were not avail-
able for assessment in HUNT-2.
Our study had a cross sectional design which gives a
snapshot of the cancer survivors’ situation without
opportunities to identify causal connection. We do not
have any information concerning the non-responders to
HUNT-2. The variables selected for the HUNT-study
did not cover all variables relevant for the study of can-
cer survivors (e.g. pain was not covered). The Cancer
Registry of Norway (CRN) does not have valid data on
cancer treatment, which would have been highly rele-
vant information. The survey was sampled some years
ago. However, we cannot see that this delay influences
the aims and results of this study. The cases have been
divided into two subgroups under the same conditions
related treatment and follow-up. Even if we take into
account that new treatment modalities have emerged
from the sampling of this study, the pattern of problems
Table 4 Somatic and mental morbidity of cancer
survivors and controls
Variables Survivors
(N =
334)
Controls
(N =
1,670)
p-
value
Effect
size
Self-rated health <0.001* 0.26
Good health 151 (46) 971 (59)
Poor health 178 (54) 687 (41)
Functional impairment
Physical impairment 76 (23) 230 (13) <0.001* 0.26
Mental impairment 14 (4) 62 (4) 0.62*
Somatic diseases
Infarction, angina or stroke 44 (13) 223 (13) 0.85*
Diabetes 14 (4) 73 (4) 0.83*
Thyroid diseases 48 (14) 121 (7) 0.001* 0.23
Osteoporosis 17 (5) 65 (4) 0.84*
Arthritis, arthrosis 80 (24) 408 (24) 0.34*
Musculo-skeletal diseases 54 (16) 207 (12) 0.07*
≥1 comorbid disease(s) 169 (51) 809 (48) 0.99*
Significant somatic symptoms
Muscular pain and stiffness
affecting
activities of daily living last
month
66 (20) 322 (19) 0.70*
Gastrointestinal symptoms
last year
36 (11) 165 (10) 0.82*
Headache last year 76 (23) 428 (26) 0.19*
Regular use of medication last
year
Daily use of any
medication
190 (57) 822 (49) 0.01* 0.16
Analgesics 45 (14) 179 (11) 0.15*
Psychotropics 56 (17) 187 (11) 0.02* 0.17
Antihypertensives 75 (23) 361 (22) 0.98*
Mental variables
HADS-Anxiety, mean (SD)
a 4.8 (3.8) 4.0 (3.4) 0.001* 0.20
HADS-Anxiety caseness, N (%) 77 (25) 208 (13) <0.001* 0.31
HADS-Depression, mean (SD)
a 4.2 (3.3) 4.1 (3.2) 0.41*
HADS-Depression caseness, N
(%)
47 (15) 230 (14) 0.73*
Self-esteem score, mean (SD) 5.6 (1.9) 5.7 (1.6) 0.39*
Sleeping problems, N (%) 89 (29) 385 (24) 0.35*
Alcohol problems, N (%) 25 (8) 147 (8) 0.57*
Lifestyle variables
BMI, mean (SD) 27.6 (4.5) 27.4 (4.2) 0.84*
Physical activity, N (%) 0.42*
Minimal 86 (31) 475 (34)
Moderate or more 188 (69) 930 (66)
Daily smoker 64 (23) 308 (22) 0.49*
Framingham risk score
Framingham sum score,
mean (SD)
16.4 (2.9) 16.0 (2.9) 0.01 0.14
Framingham risk >20%, N
(%)
198 (58) 867 (52) 0.12
* Adjusted for age and sex a Non-parametric test.
Table 5 Multivariate logistic regression analysis with
cancer survivors (N = 334) versus controls (N = 1,670) as
dependent variable
Independent variables OR 95% CI P
Age 1.09 1.03 - 1.15 0.003
Female (male = reference) 1.57 1.12 - 2.20 0.009
Pensioned (not pensioned = reference) 1.28 0.92 - 1.37 0.14
Economic problems last year 0.54 0.36 - 0.80 0.002
Poor self-rated health (good = reference) 1.27 0.95 - 1.71 0.11
Physical impairment present 1.66 1.17 - 2.37 0.005
Thyroid diseases 2.05 1.39 - 3.03 <0.001
Daily use of psychotropics 1.29 0.89 - 1.88 0.18
HADS Anxiety 1.03 0.99 - 1.07 0.14
Framingham risk score 0.95 0.89 - 1.00 0.07
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lighted in our study still seem appropriate.
Conclusion
In this controlled population-based study of cancer sur-
vivors age 60-69 years, we observed few significant dif-
ferences between LTS and STS. In accordance with
other studies of elderly cancer survivors, we found sig-
nificant differences between survivors and controls
drawn at random within psychosocial, morbidity and
lifestyle variables. However, none of these differences
reached clinical significance. Anyway, health care per-
sonnel are recommended to identify individuals with
health problems like thyroid disease among the cancer
survivors, and to assess their physical and mental health
in order to identify physical diseases and mental distress.
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